Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency
Crossref DOI link: https://doi.org/10.1007/s10875-016-0243-z
Published Online: 2016-02-24
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rojavin, Mikhail A.
Hubsch, Alphonse
Lawo, John-Philip
License valid from 2016-02-24